Acute stroke imaging research roadmap II

Stroke

Volumn 44, Issue 9, 2013, Pages 2628-2639

  Wintermark, Max ^a,c   Albers, Gregory W ^d   Broderick, Joseph P ^e   Demchuk, Andrew M ^f   Fiebach, Jochen B ^g   Fiehler, Jens ^h   Grotta, James C ⁱ   Houser, Gary ^j   Jovin, Tudor G ^k   Lees, Kennedy R ^l   Lev, Michael H ^m   Liebeskind, David S ⁿ   Luby, Marie ^o,p   Muir, Keith W ^l   Parsons, Mark W ^q   Von Kummer, Rüdiger ^r   Wardlaw, Joanna M ^s   Wu, Ona ^m   Yoo, Albert J ^m   Alexandrov, Andrei V ^t   Alger, Jeffry R ⁿ   Aviv, Richard I ^u   Bammer, Roland ^d   Baron, Jean Claude ^v,w   Calamante, Fernando ^x   Campbell, Bruce C V ^y   Carpenter, Trevor C ^s   Christensen, Søren ^d   Copen, William A ^m   Derdeyn, Colin P ^z   Haley, E Clarke ^b   Khatri, Pooja ^e   Kudo, Kohsuke ^aa   Lansberg, Maarten G ^d   Latour, Lawrence L ^o,p   Lee, Ting Yim ^ab   Leigh, Richard ^ac   Lin, Weili ^ad,ae,af   Lyden, Patrick ^ag   Mair, Grant ^ah   Menon, Bijoy K ^f   Michel, Patrik ^c   Mikulik, Robert ^ai   Nogueira, Raul G ^aj   Ostergaard, Leif ^ak   Pedraza, Salvador ^al   Riedel, Christian H ^am   Rowley, Howard A ^an   Sanelli, Pina C ^ao   Sasaki, Makoto ^ap   Saver, Jeffrey L ⁿ   Schaefer, Pamela W ^m   Schellinger, Peter D ^aq   Tsivgoulis, Georgios ^h   Wechsler, Lawrence R ^as   White, Philip M ^at   Zaharchuk, Greg ^d   Zaidat, Osama O ^au   Davis, Stephen M ^y   Donnan, Geoffrey A ^x   Furlan, Anthony J ^av   Hacke, Werner ^aw   Kang, Dong Wha ^ax   Kidwell, Chelsea ^ay   Thijs, Vincent N ^az,ba   Thomalla, Götz ^t,ar   Warach, Steven J ^bb,bc   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^j Stroke Group   (United States)

^k UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^l UNIVERSITY OF GLASGOW   (United Kingdom)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^p NATIONAL INSTITUTES OF HEALTH   (United States)

^q UNIVERSITY OF NEWCASTLE   (Australia)

^r UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^s UNIVERSITY OF EDINBURGH   (United Kingdom)

^t UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^u SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^v INSERM   (France)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^x FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^y UNIVERSITY OF MELBOURNE   (Australia)

^z WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^ab UNIVERSITY OF WESTERN ONTARIO   (Canada)

^ac JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ad UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ae NORTH CAROLINA STATE UNIVERSITY   (United States)

^af UNIVERSITY OF NORTH CAROLINA   (United States)

^ag CEDARS SINAI MEDICAL CENTER   (United States)

^ah WESTERN GENERAL HOSPITAL   (United Kingdom)

^ai ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^aj EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ak AARHUS UNIVERSITY HOSPITAL   (Denmark)

^al HOSPITAL JOSEP TRUETA   (Spain)

^am UNIVERSITY OF KIEL   (Germany)

^an UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^ao NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^ap IWATE MEDICAL UNIVERSITY   (Japan)

^aq KLINIKUM MINDEN   (Germany)

^ar UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^as UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^at NEWCASTLE UNIVERSITY   (United Kingdom)

^au MEDICAL COLLEGE OF WISCONSIN   (United States)

^av CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aw UNIVERSITY OF HEIDELBERG   (Germany)

^ax Asan Medical Center   (South Korea)

^ay GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^az UNIVERSITY OF LEUVEN   (Belgium)

^ba UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bb UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^bc UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Angiography; Clinical trial; Computed tomography; Consensus; Imaging; Magnetic resonance imaging; Stroke; Thrombolysis

Indexed keywords

BIOLOGICAL MARKER; TISSUE PLASMINOGEN ACTIVATOR;

ADVERSE OUTCOME; ARTERY OCCLUSION; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; DEVICE SAFETY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDICAL RESEARCH; PATIENT SELECTION; PERFUSION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION AND FORECASTING; PRIORITY JOURNAL; REPERFUSION; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 84884503328     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002015     Document Type: Article

References (81)

1. Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, et al; National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element Working Group. Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke. 2012;43:967-973.
2. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981;12:723-725.
3. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.
4. Lassen NA. Pathophysiology of brain ischemia as it relates to the therapy of acute ischemic stroke. Clin Neuropharmacol. 1990;13(Suppl 3):S1-S8.
5. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD; Calgary Stroke Program. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43:1013-1017.
6. Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol. 2005;57:848-854.
7. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233-2240.
8. Puntmann VO. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J. 2009;85:538-545.
9. Schellinger PD, Bath PM, Lees KR, Bornstein NM, Uriel E, Eisert W, et al; European Stroke Organisation Outcomes Working Group. Assessment of additional endpoints for trials in acute stroke - what, when, where, in who? Int J Stroke. 2012;7:227-230.
10. Lees KR, Bath PM, Schellinger PD, Kerr DM, Fulton R, Hacke W, et al; European Stroke Organization Outcomes Working Group. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012;43:1163-1170.
11. Howard G, Waller JL, Voeks JH, Howard VJ, Jauch EC, Lees KR, et al. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke. 2012;43:664-669.
12. Johnston KC, Barrett KM, Ding YH, Wagner DP; Acute Stroke Accurate Prediction Investigators. Clinical and imaging data at 5 days as a surrogate for 90-day outcome in ischemic stroke. Stroke. 2009;40:1332-1333.
13. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC; ASAP Investigators. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke. 2009;40:2422-2427.
14. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
15. Furtado AD, Smith WS, Koroshetz W, Dillon WP, Furie KL, Lev MH, et al. Perfusion CT imaging follows clinical severity in left hemispheric strokes. Eur Neurol. 2008;60:244-252.
16. Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx. 2004;1:189-195.
17. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-1181.
18. Wardlaw, JM, Dennis MS, Lindley RI, Warlow CP, Sandercock PAG, Sellar RJ. Does early reperfusion of a cerebral infarct influence cerebral infarct swelling in the acute stage or the final clinical outcome? Cerebrovasc Dis 1993;3:86-93
19. Wardlaw JM, Sellar R. A simple practical classification of cerebral infarcts on CT and its interobserver reliability. AJNR Am J Neuroradiol. 1994;15:1933-1939.
20. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [ist-3]): a randomised controlled trial. Lancet. 2012;379:2352-2363
21. Wardlaw JM, Farrall AJ, Perry D, von Kummer R, Mielke O, Moulin T, et al; Acute Cerebral CT Evaluation of Stroke Study (ACCESS) Study Group. Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke. 2007;38:1250-1256.
22. Yoo AJ, Sheth KN, Kimberly WT, Chaudhry ZA, Elm JJ, Jacobson S, et al. Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis. 2012; http://dx.doi.org/10.1016/j. jstrokecerebrovasdis.2012.01.002.
23. Hom J, Dankbaar JW, Soares BP, Schneider T, Cheng SC, Bredno J, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol. 2011;32:41-48.
24. Aviv RI, d'Esterre CD, Murphy BD, Hopyan JJ, Buck B, Mallia G, et al. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology. 2009;250:867-877.
25. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477.
26. Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, et al. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke. 2010;41:e123-e128.
27. Batra A, Latour LL, Ruetzler CA, Hallenbeck JM, Spatz M, Warach S, et al. Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke. J Cereb Blood Flow Metab. 2010;30:1188-1199.
28. Wardlaw J, Muir KW, Macleod MJ, Weir C, McVerry F, Carpenter T, et al. Clinical relevance and practical implications for trials of perfusion and angiographic imaging in patients with acute ischaemic stroke: a multicentre cohort imaging study. J Neurol Neurosurg Psychiatry 2013; http://dx.doi.org/10. 1136/jnnp-2012-304807.
29. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
30. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73:1066-1072.
31. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-923.
32. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903.
33. Tomsick T. TIMI, TIBI, TICI: i came, I saw, I got confused. AJNR Am J Neuroradiol. 2007;28:382-384.
34. Zaidat OO, Yoo AJ, Khatri P, Tomsick T, von Kummer R, Saver JL, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. In press.
35. Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26:1012-1021.
36. Lev MH, Romero JM, Goodman DN, Bagga R, Kim HY, Clerk NA, et al. Total occlusion versus hairline residual lumen of the internal carotid arteries: accuracy of single section helical CT angiography. AJNR Am J Neuroradiol. 2003;24:1123-1129.
37. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke. 1992;23:317-324.
38. Goldmakher GV, Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Halpern EF, et al. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke. 2009;40:134-139.
39. Riedel CH, Jensen U, Rohr A, Tietke M, Alfke K, Ulmer S, et al. Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced computed tomography reconstructions. Stroke. 2010;41:1659-1664.
40. Riedel CH, Zoubie J, Ulmer S, Gierthmuehlen J, Jansen O. Thin-slice reconstructions of nonenhanced CT images allow for detection of thrombus in acute stroke. Stroke. 2012;43:2319-2323.
41. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993;14:3-13.
42. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42:1775-1777.
43. Flacke S, Urbach H, Keller E, Träber F, Hartmann A, Textor J, et al. Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology. 2000;215:476-482.
44. Kim HS, Lee DH, Choi CG, Kim SJ, Suh DC. Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis. AJR Am J Roentgenol. 2006;187:W650-W657.
45. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005;26:618-624.
46. Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, et al; SITS Investigators. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry. 2009;80:273-278.
47. Sanossian N, Ovbiagele B, Saver JL, Alger JR, Starkman S, Kim D, et al. Leukoaraiosis and collaterals in acute ischemic stroke. J Neuroimaging. 2011;21:232-235.
48. Al-Ali F, Jefferson A, Barrow T, Cree T, Louis S, Luke K, et al. The capillary index score: rethinking the acute ischemic stroke treatment algorithm. Results from the Borgess Medical Center Acute Ischemic Stroke Registry. J Neurointerv Surg. 2013;5:139-143.
49. Alexandrov AV, Wojner AW, Grotta JC; CLOTBUST Investigators. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke. J Neuroimaging. 2004;14:108-112.
50. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Garami Z, Barreto A, et al; CLOTBUST-PRO Investigators. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO). Int J Stroke. 2008;3:66-72.
51. Nedelmann M, Stolz E, Gerriets T, Baumgartner RW, Malferrari G, Seidel G, et al; TCCS Consensus Group. Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke. 2009;40:3238-3244.
52. Krafft PR, Bailey EL, Lekic T, Rolland WB, Altay O, Tang J, et al. Etiology of stroke and choice of models. Int J Stroke. 2012;7:398-406.
53. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
54. Suh SH, Cloft HJ, Fugate JE, Rabinstein AA, Liebeskind DS, Kallmes DF. Clarifying differences among thrombolysis in cerebral infarction scale variants: is the artery half open or half closed? Stroke. 2013;44:1166-1168.
55. Ali M, Bath P, Brady M, Davis S, Diener HC, Donnan G, et al; VISTA Steering Committees. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke. 2012;7:133-138.
56. Stroke Imaging Repository (STIR) web site. http://stir.ninds.nih.gov/. Accessed May 10, 2013.
57. Christensen S, Mouridsen K, Wu O, Hjort N, Karstoft H, Thomalla G, et al. Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke. 2009;40:2055-2061.
58. Kudo K, Christensen S, Sasaki M, Østergaard L, Shirato H, Ogasawara K, et al; Stroke Imaging Repository (STIR) Investigators. Accuracy and reliability assessment of CT and MR perfusion analysis software using a digital phantom. Radiology. 2013;267:201-211.
59. Wu O. International stroke database: perfusion simulation data. http://www.strokedatabases.org/pages/perfusion-sim-data.html. Accessed May 10, 2013.
60. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med. 1996;36:715-725.
61. Campbell BC, Tu HT, Christensen S, Desmond PM, Levi CR, Bladin CF, et al. Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging. Arch Neurol. 2012;69:46-50.
62. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, et al. Acute stroke imaging research roadmap. Stroke. 2008;39:1621-1628.
63. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, et al. Acute stroke imaging research roadmap. AJNR Am J Neuroradiol. 2008;29:e23-e30.
64. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89:212-216.
65. Zaharchuk G, El Mogy IS, Fischbein NJ, Albers GW. Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke. 2012;43:1843-1848.
66. An H, Liu Q, Chen Y, Lin W. Evaluation of MR-derived cerebral oxygen metabolic index in experimental hyperoxic hypercapnia, hypoxia, and ischemia. Stroke. 2009;40:2165-2172.
67. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med. 2003;9:1085-1090.
68. Xu C, Schmidt WU, Villringer K, Brunecker P, Kiselev V, Gall P, et al. Vessel size imaging reveals pathological changes of microvessel density and size in acute ischemia. J Cereb Blood Flow Metab. 2011;31:1687-1695.
69. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med. 1998;40:793-799.
70. Donahue MJ, van Laar PJ, van Zijl PC, Stevens RD, Hendrikse J. Vascular space occupancy (VASO) cerebral blood volume-weighted MRI identifies hemodynamic impairment in patients with carotid artery disease. J Magn Reson Imaging. 2009;29:718-724.
71. Mandell DM, Han JS, Poublanc J, Crawley AP, Fierstra J, Tymianski M, et al. Quantitative measurement of cerebrovascular reactivity by blood oxygen level-dependent MR imaging in patients with intracranial stenosis: preoperative cerebrovascular reactivity predicts the effect of extracranial-intracranial bypass surgery. AJNR Am J Neuroradiol. 2011;32:721-727.
72. Hui ES, Fieremans E, Jensen JH, Tabesh A, Feng W, Bonilha L, et al. Stroke assessment with diffusional kurtosis imaging. Stroke. 2012;43:2968-2973.
73. Tournier JD, Calamante F, Connelly A. Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage. 2007;35:1459-1472.
74. Golestani AM, Tymchuk S, Demchuk A, Goodyear BG; VISION-2 Study Group. Longitudinal evaluation of resting-state FMRI after acute stroke with hemiparesis. Neurorehabil Neural Repair. 2013;27:153-163.
75. Carter AR, Astafiev SV, Lang CE, Connor LT, Rengachary J, Strube MJ, et al. Resting interhemispheric functional magnetic resonance imaging connectivity predicts performance after stroke. Ann Neurol. 2010;67:365-375.
76. Shehzad Z, Kelly AM, Reiss PT, Gee DG, Gotimer K, Uddin LQ, et al. The resting brain: unconstrained yet reliable. Cereb Cortex. 2009;19:2209-2229.
77. Gupta R, Phan CM, Leidecker C, Brady TJ, Hirsch JA, Nogueira RG, et al. Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining. Radiology. 2010;257:205-211.
78. Carey LM, Seitz RJ. Functional neuroimaging in stroke recovery and neurorehabilitation: conceptual issues and perspectives. Int J Stroke. 2007;2:245-264.
79. Carter AR, Shulman GL, Corbetta M. Why use a connectivity-based approach to study stroke and recovery of function? Neuroimage. 2012;62:2271-2280.
80. Stinear CM, Ward NS. How useful is imaging in predicting outcomes in stroke rehabilitation? Int J Stroke. 2013;8:33-37.
81. Alzheimer's Disease Neuroimaging Initiative website. http://www.adniinfo. org/. Accessed May 10, 2013.